Sankar Subramanian's Form 4 filing
Nautilus Biotechnology, Inc. (NAUT) · filed Sep 28, 2022
- Accession no.
- 0001808805-22-000101
- Filed
- Sep 28, 2022
- Trade date
- Sep 26-27, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $30.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sankar SubramanianCIK 0001856744 | Officer (Senior VP, Product Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2022 | Common Stock | PPurchaseAcquired | +10,000 | $2.03 | +$20,300 | 86,250 | Direct | |
| Sep 27, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $2.03 | +$10,150 | 91,250 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.